Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Jun 12, 2006
Strategy
Back in the limelight
...In 2000, ThromboGenics in-licensed microplasmin, which was discovered by different researchers at Katholieke. In 2001,
East Hill Advisors
...
Read More
BioCentury
|
Jun 5, 2006
Finance
Ebb & Flow
...could be aiming to raise about E40 million ($51 million). ThromboGenics raised $12.8 million from
East Hill Advisors
...
Read More
BioCentury
|
May 10, 2001
Financial News
ThromboGenics raises $12.8 million
...ThromboGenics (Dublin, Ireland) raised $12.8 million in a private financing with
East Hill Advisors
. ThromboGenics is developing compounds...
Read More
Items per page:
10
1 - 3 of 3
BioCentury
|
Jun 12, 2006
Strategy
Back in the limelight
...In 2000, ThromboGenics in-licensed microplasmin, which was discovered by different researchers at Katholieke. In 2001,
East Hill Advisors
...
Read More
BioCentury
|
Jun 5, 2006
Finance
Ebb & Flow
...could be aiming to raise about E40 million ($51 million). ThromboGenics raised $12.8 million from
East Hill Advisors
...
Read More
BioCentury
|
May 10, 2001
Financial News
ThromboGenics raises $12.8 million
...ThromboGenics (Dublin, Ireland) raised $12.8 million in a private financing with
East Hill Advisors
. ThromboGenics is developing compounds...
Read More
Items per page:
10
1 - 3 of 3
Previous page
Next page